Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00414453 · ClinicalTrials.gov registry record · Phase 4
Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis
A Phase 4 study, sponsored by University of Rochester.
- Terminated
- Registry status
- Phase 4
- Development phase
- 19
- Enrollment target
NCT00414453 is a Phase 4 study that was terminated before completion, run by University of Rochester. The registered enrollment target is 19 participants.
The verdict
NCT00414453, a Phase 4 study, was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 19 participants
- Enrollment target
Study Summary
This study will determine whether treatment with an extended-release opioid or topical lidocaine is effective in relieving distal symmetric lower extremity burning pain associated with multiple sclerosis (MS). If treatment with topical lidocaine is efficacious, it will have important implications for understanding this chronic pain syndrome, which is widely assumed to be caused by central nervous system pathology.
Interventions
- DRUG Lidocaine patch 5%
- DRUG Extended-release oxycodone
- DRUG Placebo extended-release oxycodone pills
- DRUG Placebo lidocaine patches
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2007-01 |
| Est. Completion | 2011-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00414453
The ClinicalTrials.gov registry entry for NCT00414453 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Lidocaine patch 5% is the first listed.
NCT00414453 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00414453 about?
NCT00414453 is a clinical study titled "Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis". This study will determine whether treatment with an extended-release opioid or topical lidocaine is effective in relieving distal symmetric lower extremity burning pain associated with multiple sclerosis (MS). If treatment with topical lidocaine is efficacious, it will have important implications fo...
What is the current status of trial NCT00414453?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2007-01. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00414453?
The interventions under investigation include: Lidocaine patch 5% (DRUG), Extended-release oxycodone (DRUG), Placebo extended-release oxycodone pills (DRUG), Placebo lidocaine patches (DRUG).
Who is sponsoring clinical trial NCT00414453?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.